Clin Osteol 2008; 13(4): 154-157

Ultrasonography of the parathyroid glands in chronic kidney diseaseReview articles

J. Horáček

Ultrasound examination is effective for imaging enlarged parathyroid glands, in particular prior to elective surgery for hyperparathy­ roidism. It is also beneficial for assessing the effect of conservative treatment. However, its reliability is largely dependent on both the equipment quality and the sonographer's experience with the neck region examination. In common sites, the latest technology is usu­ ally capable of resolving formations of the largest sizes over 5 mm. Sometimes, ultrasound examination is combined with fine-needle aspiration biopsy. In chronic kidney disease, chronic stimulation leads to parathyroid hyperplasia - first diffuse and later nodular. Ultrasonography helps to characterize the changes and may contribute to making therapeutic decisions. The correct description should comprise the number and location of visible parathyroid glands, their size, structure and type of vascularization.

Keywords: ultrasonography, parathyroid glands, chronic kidney disease

Published: December 11, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Horáček J. Ultrasonography of the parathyroid glands in chronic kidney disease. Osteologický bulletin. 2008;13(4):154-157.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ruckert Y, Gerl H, Ruckert RI, Wermke W. Value of colour Doppler in the pre­ operative localization of parathyroid tumours. Eur J Ultrasound 1996;4:107-114. Go to original source...
    2. Ishibashi M, Nishida H, Hiromatsu Y, Kojima K, Tabuchi, E, Hayabuchi N. Com­ parison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound and MRI for localization ofabnormal parathyroid glands. J Nucl Med 1998;39:320-324.
    3. Kebapci M, Entok E, Kebapci N, Adapinar B. Preoperative evaluation of parathy­ roid lesions in patients with concomitant thyroid disease: role of high resolution ultrasonography and dual phase technetium 99m sestamibi scintigraphy. J Endo­ crinol Invest 2004;27:24-30. Go to original source...
    4. Alexandrides TK, Kouloumbi K, Vagenakis AG, Yarmenitis S, Spyridonidis T, Vassilakos P, Apostopoulos D. The value of scintigraphy in the preoperative loca­ lization of parathyroid glands in patinets with primary hyperparathyroidism and concomitant thyroid disease. Hormones (Athens) 2006;5:42-51. Go to original source...
    5. Horáček J. Sonografie příštitných tělísek. In: Dusilová Sulková S, ed: Renální osteopatie. Praha, Maxdorf, 2007:79-82.
    6. Huppert BJ, Reading CC. The parathyroid glands. In:Rumack CM, Wilson SR, Charbonean JW, eds:Diagnostic ultrasound (3rd Ed.). St. Louis, Elsevier Mosby, 2005:771-794.
    7. Nozeran S, Duquenne M, Guyetant S, Rodien P, Rohmer V, Ronceray J, SaintAndré JP, Bigorgne JC. Diagnosis of parathyroid cysts: value of parathyroid hor­ mone level in puncture fluid. Presse Med 2000;29:939-41.
    8. Fukugawa M, Kitaoka M, Tominaga Y, Akizawa T, Kurokawa K. Selective per­ cutaneous ethanol injection therapy (PEIT) of the parathyroid in chronic dialysis patients - the Japanese strategy. Nephrol Dial Transplant 1999;14:2574-2577. Go to original source...
    9. Vulpio C, Bossola M, De Gaetano A, Maresca G, Di Stasio E, Spada PL, Romitelli F, Luciani G, Castagneto M. Ultrasound patterns of parathyroid glands in chronic hemodialysis patients with secondary hyperparathyroidism. Am J Nephrol 2008;28:589-597. Go to original source...
    10. Okuno S, Ishimura E, Kitatani K, Chou H, Nagasue K, Maekawa K, Izumotani K, Yamakawa T, Imanishi Y, Shoji T, Inaba M, Nishizawa Y. Relationship between parathyroid gland size and responsiveness to maxacalcitol therapy in patients with secondary hyperparathyroidism. Nephrol Dial Transplant 2003;18:2613-2621. Go to original source...
    11. Taniguchi M, Tokumoto M, Tsuruya K, Hirakata H, Iida M. Intravenous calcitriol therapy in an early stage prevents parathyroid gland growth. Nephrol Dial Transplant 2008;23:3662-3669. Go to original source...
    12. Pavlovic D, Tomic Brzac H. Ultrasonographic evaluation of parathyroid hyperpla­ sia in dialysis patients. The Scientific World Journal 2006;6:1599-1608. Go to original source...
    13. Onoda N, Kurihara S, Sakurai Y, Owada K, Osono E, Adachi H, Suga M, Yone­ shima H. Evaluation of blood supply of the parathyroid glands in secondary hy­ perparathyroidism compared to histopathology. Nephrol Dial Transplant 2003;18, Suppl 3:iii34-iii37. Go to original source...
    14. Tominaga Y, Tanaka Y, Sato K, Nagasaka T, Takagi H. Histopathology, patholo­ gy, and indications for surgical treatment of renal hyperparathyroidism. Semin Surg Oncol 1997;13:78-86. Go to original source...
    15. Fukugawa M, Kitaoka M, Yi H. Serial evaluation of parathyroid size by ultraso­ nography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients. Nephron 1994;68:221-228. Go to original source...
    16. Taniguchi M, Tokumoto M, Matsuo D, Motoyama K, Sugitani A, Kuroki S, Youtsueda H, Tsuruya K, Hirakata H, Iida M. Persistent hyperparathyroidism in renal allograft recipients: Vitamin D receptor, calcium-sensing receptor, and apoptosis. Kidney Int 2006;70:363-370. Go to original source...

    Return to the content


    Clinical Osteology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.